Upstate News

June 3, 2010
Darryl Geddes 315 464-4828

Leading cancer researchers gather at Upstate for symposium, opening of Cancer Research Institute

SYRACUSE, N.Y.— Noted cancer researchers will participate in a Cancer Research Symposium at Upstate Medical University as part of the grand opening activities for the Upstate Cancer Research Institute June 10.

The Upstate Cancer Research Institute, located on the sixth floor of Weiskotten Hall, will bring together basic scientists and clinicians to escalate Upstate’s cancer activity and expedite the discover of new treatments for cancer patients. The opening ceremony is set for June 10 at 11 a.m. on the ninth floor of Weiskotten Hall. It is free and open to the public.

At 1 p.m. the public is invited to attend a Cancer Research Symposium highlighting the work of seven leading cancer researchers. The symposium, which takes place in the Ninth Floor Auditorium of Weiskotten Hall, features the following speakers:

1 to 1:30 p.m.— Ziwei Huang, Ph.D., director of SUNY Upstate Cancer Research Institute, professor and chair of Department of Pharmacology, presentation: “Overview of SUNY Upstate Cancer Research Institute & Discovery of New Cancer Medicine Targeting Cancer Apoptosis & Metastasis.”

1:30 to 2 p.m.—Curt Civin, M.D., professor and associate dean for research and director of the Center for Stem Cell Biology and Regenerative Medicine at the University of Maryland School of Medicine, presentation: “MicroRNA Maestros of Hematopoiesis & Leukemia.”

2 to 2:30 p.m.—Michael Cosgrove, Ph.D., assistant professor of biology at Syracuse University, presentation: “Discovery & Characterization of a Novel Class of Mixed Lineage Leukemia Core Complex Inhibitors.”

2:30 to 3 p.m.—Saïd M. Sebti, Ph.D., associate director of the Moffitt Research Institute, program leader of Drug Discovery, professor of oncologic science and member-in-residence of the Moffit Cancer Center, presentation: “Signal Transduction, A Goldmine of Anti-Cancer Targets: From Chemical Biology to Hypothesis-Driven Clinical Trials.”

3 to 3:15 p.m. Break

3:15 to 3:45 p.m.—Matthew Pincus, M.D., Ph.D., professor of pathology at SUNY Downstate and chief of the Department of Pathology and Laboratory Medicine at New York Harbor VA Medical Center, presentation: “PNC-27: A New Anti-Cancer Peptide That Kills Cancer Cells, But Not Normal Cells, by a Novel Mechanism. ‘Design of PNC Anti-Cancer Peptides & Their Selective Lethal Effects On Cancer Cells.’”

3:45 to 4:15 p.m.— Josef Michl, M.D., associate professor of pathology at SUNY Downstate, presentation: “PNC-27: A New Anti-Cancer Peptide That Kills Cancer Cells, But Not Normal Cells, by a Novel Mechanism. ‘Killing Mechanism by PNC-Anti-Cancer Peptides: “Shooting” the Cells.’”

4:15 to 4:45 p.m.— Debashis Ghosh, MSc, Ph.D., principal research scientist and principal investigator and associate professor of oncology at the University at Buffalo and principal investigator at Hauptman-Woodward Medical Research Institute, Roswell Park Cancer Institute, presentation: “Hormones & Cancer: Structural Biology Lights Up the Targets.”

The Upstate Cancer Research Institute is a multidisciplinary enterprise, encompassing the efforts of dozens of Upstate faculty and collaborators of institutions in Central New York, with the goal to translate research into potential cures, technologies and other products.

For more information on the day’s activities, contact Kay Magnarelli at 464-7949.

Search Upstate News

Upstate in the News

News Feed
Subscribe to RSS Feed
Follow us on Twitter